Key points are not available for this paper at this time.
Hypothermic machine perfusion was associated with a reduced risk of delayed graft function and improved graft survival in the first year after transplantation. (Current Controlled Trials number, ISRCTN83876362.)
Moers et al. (Wed,) studied this question.